Hilltelligence markHilltelligence
Archived This bill is from the 118th Congress (2023–2024) and is no longer under active consideration.
Bills/H.R. 383118th Congress

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

House: Referred
Cosponsors
24
Introduced
2023-01-17
Last action
2023-01-27

Referred to the Subcommittee on Health.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the Subcommittee on Health.

  2. House

    Referred to the House Committee on Energy and Commerce.

  3. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.